Discover Biotech Webinar Pharma FDA & EMA ONCOLife Contact

ONCOLife

Restoring Proteostasis May Boost T Cell Function and Open a New Route for Immunotherapy

Clinical Trials

Phase 3 MagnetisMM-5 Trial Supports Earlier Use of Elranatamab in Relapsed Myeloma

ONCOLife

Real-World Analysis Links Community Oncology Care to Longer Survival in Multi-Cancer

ONCOLife

Early CAR T-Cell Intervention Shows Disease-Eradication Potential in High-Risk Myeloma

ONCOLife

Long-Term Data Show Taletrectinib Delivers High Response Rates in ROS1+ NSCLC

FDA & EMA

FDA Grants Breakthrough Status to First Viral Liquid Biopsy in Hepatocellular Carcinoma

ONCOLife

PLN-101095 Plus Pembrolizumab Shows Durable Responses in ICI-R Solid Tumors

ONCOLife

Daraxonrasib Doubles Overall Survival in Previously Treated Metastatic Pancreatic Cancer

ONCOLife Issues

Featured Articles

OPTIMAL Data Support TLX597-Tx as a Next-Gen Radioligand Therapy in Prostate Cancer

30 April 2026

Phase 2 OPTIMAL-PSMA dosimetry data suggest that TLX597-Tx, a next-generation PSMA-targeting radioligand therapy, demonstrated low salivary gland and kidney uptake in metastatic castration-resistant prostate cancer....

Trending Articles

FDA Grants Breakthrough Status to WU-CART-007 for T-Cell Leukemias and Lymphomas

New IHC Biomarker Test Predicts Which Gastric Cancer Patients Benefit from Immunotherapy

ONCOLife

30 March 2026

Nonviral Gene Delivery Platform Offers Promise for Cancer Treatment and Cell Therapy

ONCOLife

30 March 2026

Immunotherapy Boosts Chemo Cutting Recurrence Risk by 50% in Colon Cancer

ONCOLife

30 March 2026

AI Predicts Chemotherapy Benefit in Breast Cancer Using Routine Pathology Slides

Clinical Trials

30 March 2026

FDA Approves Agilent’s PD-L1 Test to Guide KEYTRUDA Use in Esophageal and GEJ Carcinoma

Light-Activated Copper Nanoparticles Trigger Cuproptosis in Drug-Resistant Cancer Cells

ONCOLife

27 March 2026

New Protein Modification Linked to IDH-Mutant Cancers Opens Therapeutic Possibilities

ONCOLife

26 March 2026

BioNTech Showcases Promising Bispecific and ADC Data in Lung Cancer at ELCC 2026

ONCOLife

25 March 2026

Sunvozertinib Outperforms Chemo in First-Line EGFR Exon 20 Insertion NSC Lung Cancer

ONCOLife

22 March 2026

Magnetic Nanoparticle-Guided Hyperthermia Opens a New Path for Advanced Solid Tumors

TG Therapeutics Secures $500M to Advance BRIUMVI in Relapsing Multiple Sclerosis

Biotech

20 March 2026

Targeted Bladder Cancer Therapy Erda-iDRS Achieves 89% Response Rate and PDC

ONCOLife

15 March 2026

Atirmociclib Reduces Progression Risk by 40% in CDK4/6 Metastatic Breast Cancer

ONCOLife

17 March 2026

TALAPRO-3 Trial Supports Early Use of Talazoparib in HRR+ mCS Prostate Cancer

ONCOLife

20 March 2026